Institut klinicke a experimentalni mediciny (IKEM) — Prague

Public research footprint of Institut klinicke a experimentalni mediciny (IKEM), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Pulmonary Arterial Hypertension · Heart Failure With Mildly Reduced Ejection Fraction · Atherosclerotic Cardiovascular Disease

Recently updated registry entries

NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)
NCT07746895 — Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A… (Recruiting)
NCT03811561 — A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut klinicke a experimentalni mediciny (IKEM)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.